HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sanofi Catching Up To Market Growth Rates As Q3 Sales Rise Double Digits

Executive Summary

Sanofi Consumer Healthcare's second successive quarter of growth means the business is now growing almost as fast as the global OTC market. Business head Julie Van Ongevalle has won praise from the French group's CEO Paul Hudson for driving a "quite extraordinary" transformation.

You may also be interested in...

Sanofi Not Distracted By M&A Chatter As It Gets Back On Par With Market Growth

Recent market interest shown in other OTC assets will not distract Sanofi from its long-term plan to overhaul its Consumer Healthcare business, says CEO Paul Hudson. And this plan is delivering results, with Sanofi back on par with the consumer health market, posting sales up by 5% in 2021.

People On The Move: Appointments At Bayer And Sanofi

The latest consumer health industry appointments: Bayer has hired Ricardo Salazar Hernández from Sanofi as its chief medical officer; Sanofi has promoted Alberto Hernandez Lopez to the role of chief growth officer.

Euro Q4 Earnings Preview: GSK, Sanofi, Bayer And Reckitt

Major Europe-based consumer health players GSK, Sanofi, Bayer and Reckitt feature in this earnings preview, which highlights what to look out for as these four firms report their Q4 and annual results over the coming weeks.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts